This year’s American Society of Hematology Annual Meeting (ASH) annual meeting is taking place December 11-14, virtually and in-person in Atlanta, Georgia. The 2021 agenda provides attendees with the latest practice-changing advances in the prevention, diagnosis, and management of hematologic disorders.
Look out for coverage of the meeting and click here to learn more about the 2021 ASH Annual Meeting.
Survivors’ preferences for the organization and delivery of supportive care after treatment: An integrative review https://t.co/LLdw5oyp9R as always we done and interesting! Congratulations @druryal #OncoAlert
— Helena ullgren (@helitropen) January 14, 2022
Does the cancer geriatric assessment (GA) introduce bias into clinical trials? Observations from 988 prospectively recruited patients https://t.co/ET86RgQrUB @GrantWilliamsMD @AminahJatoi@WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG
— Journal of Geriatric Oncology (@JGeriOnc) January 14, 2022
Genetic and Epigenetic Insights into Cutaneous T-Cell Lymphoma by Dr. C. Tensen.
— David Henry (@davidhenrymd) January 17, 2022
A complex topic but always helpful when bench to bedside advances help in our understanding and therapy of this uncommon diseasehttps://t.co/7jRiHHCLIr pic.twitter.com/HeS3qAvazC
Genetic and Epigenetic Insights into Cutaneous T-Cell Lymphoma by Dr. C. Tensen.
— David Henry (@davidhenrymd) January 17, 2022
A complex topic but always helpful when bench to bedside advances help in our understanding and therapy of this uncommon diseasehttps://t.co/7jRiHHCLIr pic.twitter.com/HeS3qAvazC
Important systematic Review and Meta-Analysis of addition of Immunotherapy to chemotherapy in Extensive-Stage Small-Cell Lung Carcinoma. Just published in Oncol Ther@Hospital_FJD @OncoAlert @AEACaP_BioCaP #LCSM #SCLC
— Manuel Dómine (@ManuelDomine) January 17, 2022
(https://t.co/GZlPb5RELh) pic.twitter.com/qwCo6r5ujp
